ArticleInternal medicine (Tokyo, Japan)2017

Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.

Masashi Namba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.